Contents © Peter Wittner, Interpharm Consultancy 2020
Peter Wittner
CONFERENCE APPEARANCES and PUBLICATIONS
CONFERENCE APPEARANCES AND PUBLICATIONS
- Joint presenter of ZOOM online generic training session for FORUM Institut für Management GmbH “Generic Market Access & Pricing in Europe”, February 2022
- Joint presenter of generic training sessions at Fleming Events “Sustainable Strategies for Generics & Biosimilars”, Basel, Switzerland, February 2019.
- Presenter of two workshops for IBC Asia:-"Pharma Pricing - Commercial and Regulatory Strategies" and "Pharma Regulatory Affairs", Singapore, June 2018
- Sole presenter at Business Innovation Institute "Generics & Biosimilars training 2018", Basel, Switzerland April 2018
- Joint presenter of generic training sessions at Fleming Events “Sustainable Strategies for Generics & Biosimilars”, Basel, Switzerland, February 2018.
- Speaker and round Table Discussion chair at Marcusevans "2nd Strategic Product & Portfolio Management for Generics", Amsterdam, September 2017
- Joint presenter of generic training sessions at Fleming Events “Sustainable Strategies for Generics & Biosimilars”, Basel, Switzerland, March 2017.
- Moderator of workshop at Marcusevans "Strategic Product & Portfolio Management for Generics", Prague, September 2016
- Discussion Panel member at Virtue Insight “8th Biosimilars Congregation 2016”, London, March 2016
- Speaker and Round Table moderator at Health Networks 10th Annual World Generic Medicines Congress, Barcelona, February 2016
- Speaker at SMi conference “Biosimilars & Biobetters”, London, September 2015
- Presenter of symposium for MK Consulting on “Intellectual Property and the generic industry”, Istanbul, April 2015
- Speaker and panel member at Virtue Insight “6th Biosimilars Congregation 2015”, London, March 2015
- Speaker at SMi conference “Biosimilars & Biobetters”, London, October 2014
- Chairman, Biosimilar Drug Development World, for Health Networks, Barcelona, April 2014
- Speaker at “4th Annual Pharma PPM Toolbox” Conference for EBCG Zurich, March 2014
- Speaker at Virtue Insight “4th Biosimilars Congregation 2014”, London, February 2014
- Presenter of symposium for MK Consulting on “Intellectual Property and its effects on generic markets”, Istanbul, December 2013
- Presenter of half-day workshop for SMi on “Biosimilars - Regulatory and Commercial Issues”, London, October 2013
- Speaker at SMi conference “Biosimilars & Biobetters”, London, October 2013
- Presenter of half-day workshop for SMi on “Generics and IP”, London, July 2013
- Speaker at SMi “Generics & Patent Strategies” conference, London, May 2013
- Speaker at Virtue Insight “2nd Biosimilars Congregation 2013”, London, March 2013
- Speaker at SMi conference “Biosimilars & Biobetters”, London, September 2012
- Presenter of half-day workshop for SMi on “Biosimilars - Regulatory and Commercial Issues”, London, July 2012
- Presenter of half-day workshop for Health Networks / Terrapin on “Biosimilars - Regulatory and Commercial Issues”, London, March 2012
- Chairman of 2-day conference “Informa Life Sciences' Global Generic Strategy Summit Conference”, Berlin, September 2011
- Presenter of half-day workshop on Biosimilars for Select Biosciences, Edinburgh, July 2011
- Presenter of half-day workshops for Health Networks / Terrapin on “Biosimilars - Regulatory and Commercial Issues”, London, February 2011
- Presenter of half-day workshops for SMi on “Biosimilars - Regulatory and Commercial Issues”, London, May 2010 and September 2010
- Speaker at SMi “Generics & Supergenerics” conference, London, May 2010
- Presenter of Seminar “IP Master class”, SMi Group, London, December 2009
- Speaker at Biosimilars India conference, Mumbai, December 2009
- Presenter of 1-day workshops on “Generic Medicine, IP/Legal & Regulatory Issues” for Management Forum, Mumbai, Delhi and Hyderabad – November 2009
- Presenter of workshop on “Generic Medicine, IP/Legal & Regulatory Issues” for Management Forum, London, September 2009
- Presenter of Seminar “IP Master class”, SMi Group, London, December 2008
- Joint presenter of workshop on “Generic Strategic Business Models” together with Dr. Malcolm Ross of Generapharm. at the Global Generics Strategy Summit in Barcelona, March 2008
- Speaker at Global Generic Medicines Summit in London, February 2008 on the topic of “An Indian Overview”
- Speaker on the topic of “Creating a Generic Biodrug Company” at BioMalaysia 2007, Kuala Lumpur, November 2007
- Presenter of workshop on “Generic Medicine, IP/Legal & Regulatory Issues” for Management Forum, London, October 2007
- Presenter of seminar on “Pharmaceutical Patents and their effects on Generics” for MK Consultancy, Istanbul, October 2007
- Speaker at Informa congress on “Legal Strategies for Developing Generic Medicines” on the topic of “The regulatory framework for biosimilars”, Amsterdam, July 2007
- Presenter of symposium on “Intellectual Property and its effects on generic markets”, Istanbul, March 2007
- Speaker at ”New Trends in Generic Medicine”, Istanbul, March 2007
- Speaker at “Global Generics Summit”, London, February 2007
- Speaker at Informa’s “Generic Portfolio Management”, Vienna, December 2006
- Speaker at “IIR 5th Global Generic Strategy Symposium”, Barcelona, March 2006
- Speaker at “The Generics Marketplace” Management Forum symposium, November 2004
- Speaker on “Impact of generics on branded industry” at BHBIA symposium, June 2004
- Chairman of Independent Ethics Committee for Shandon Clinic 1997-December 2000
PUBLICATIONS
- Regular contributor to Generics Web INNsight newsletter
- Report “Biobetters - Major Players and Market Prospects” (First Word), July 2012
- Contributed to a series of reports on various topics with Decision Resources during 2009, 2010 and 2011 including:
- U.S. Healthcare Reform: Impact on the Pharmaceutical Industry
- Licensing Opportunities: Neurology
- Licensing Opportunities: Rheumatology
- Drug Price/Cost Debate: Coping with Escalating Pricing Pressures
- Paper: “Value-Added Pharma” (Decision Resources Inc), November 2008
- Research paper: “Asia: Threat or Opportunity?” (Decision Resources Inc), May 2008
- Report: “Indian Generics, 2008-2012: The Growing Threat to Westernised Markets” (Spectra Intelligence), Published: January 2008
- Author of Article “Practical Defense Strategies for Combating Generics Competition” published by Spectrum (Decision Resources Inc), July 2007
- Author of Article “An Exploration of Consolidation in the Generics Industry” published by Spectrum (Decision Resources), December 2005
- Author of report “Prescription Generics” published by Arrowhead Publishing USA, July 2005
Author of report “Generics Defence Strategies” published by Reuters Business Insight, January 2005
Author of report “Growth Strategies in Generics” published by Reuters Business Insight, July 2004
Author of report “The European Generics Outlook” published by Reuters Business Insight, April 2003
Author of report “European Generics Markets@, published by Informa Pharmaceuticals, October 2000
The list below shows conferences where I have spoken and public training sessions that I have run on behalf of specialist training organisations. I have also run in-house training sessions for a number of pharmaceutical companies.